Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07481305 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Lifestyle Change Implementation Research Network at PRC at UMass Chan

Study acronym: LCIRN
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 80 words
    • Secondary endpoints: details revised at 7 of 13 entries
  2. Recruitment opened
    • Start date changed from estimate of Jul 13, 2026 to Jul 22, 2026
    • Eligibility criteria expanded, about 14 words
    • Study site revised
    v3
  3. Start date: Apr 15, 2026 to Jul 13, 2026
    • Eligibility criteria shortened, about 6 words
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this project is to study how well the Noom digital lifestyle program works for adults who are taking Glucagon-Like Peptide-1 receptor agonist (GLP-1) medications. The study team will assess how the program affects people's behaviors and health outcomes. The team will also look at how digital lifestyle change interventions can be implemented in real-world settings, including how many people it reaches, how well it is put into practice, whether people stick with it over time, and whether it works well for different groups of people.
Trial Details
NCT Number NCT07481305
Lead Sponsor University of Massachusetts, Worcester
Collaborators: University of Massachusetts, Lowell, Centers for Disease Control and Prevention
Conditions
(from sponsor)		 GLP - 1
Related terms Body Weight, Diabetes Mellitus, Motor Activity
Enrollment 220 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov